| Genetic determinants of response to clopidogrel and cardiovascular events T Simon, C Verstuyft, M Mary-Krause, L Quteineh, E Drouet, N Méneveau, ... New England journal of medicine 360 (4), 363-375, 2009 | 2296 | 2009 |
| Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men M Mary-Krause, L Cotte, A Simon, M Partisani, D Costagliola, ... Aids 17 (17), 2479-2486, 2003 | 667 | 2003 |
| Incidence of non–AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus–infected patients M Herida, M Mary-Krause, R Kaphan, J Cadranel, I Poizot-Martin, ... Journal of Clinical Oncology 21 (18), 3447-3453, 2003 | 422 | 2003 |
| Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II) T Simon, M Mary-Krause, C Funck-Brentano, P Jaillon Circulation 103 (3), 375-380, 2001 | 390 | 2001 |
| Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus–infected patients: a case-control study nested within the French … S Lang, M Mary-Krause, L Cotte, J Gilquin, M Partisani, A Simon, ... Archives of internal medicine 170 (14), 1228-1238, 2010 | 367 | 2010 |
| Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population S Lang, M Mary-Krause, L Cotte, J Gilquin, M Partisani, A Simon, ... Aids 24 (8), 1228-1230, 2010 | 343 | 2010 |
| Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy C Piketty, H Selinger-Leneman, S Grabar, C Duvivier, M Bonmarchand, ... Aids 22 (10), 1203-1211, 2008 | 340 | 2008 |
| HIV and coronary heart disease: time for a better understanding F Boccara, S Lang, C Meuleman, S Ederhy, M Mary-Krause, ... Journal of the American College of Cardiology 61 (5), 511-523, 2013 | 323 | 2013 |
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort … Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... International journal of epidemiology 41 (2), 433-445, 2012 | 310 | 2012 |
| Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV C Piketty, H Selinger-Leneman, AM Bouvier, A Belot, M Mary-Krause, ... Journal of clinical oncology 30 (35), 4360-4366, 2012 | 208 | 2012 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 195 | 2014 |
| Frequency, determinants and consequences of delayed access to care for HIV infection in France E Lanoy, M Mary-Krause, P Tattevin, I Perbost, I Poizot-Martin, C Dupont, ... Antiviral therapy 12 (1), 89-96, 2007 | 191 | 2007 |
| Bisoprolol dose–response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study (CIBIS II) T Simon, M Mary-Krause, C Funck-Brentano, P Lechat, P Jaillon European heart journal 24 (6), 552-559, 2003 | 190 | 2003 |
| HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals S Lang, M Mary-Krause, A Simon, M Partisani, J Gilquin, L Cotte, ... Clinical Infectious Diseases 55 (4), 600-607, 2012 | 181 | 2012 |
| Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nation-wide USIC … T Simon, M Mary-Krause, JP Cambou, G Hanania, P Guéret, ... European heart journal 27 (11), 1282-1288, 2006 | 142 | 2006 |
| Combined glutathione‐S‐transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity T Simon, L Becquemont, M Mary‐Krause, I de Waziers, P Beaune, ... Clinical Pharmacology & Therapeutics 67 (4), 432-437, 2000 | 134 | 2000 |
| Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis F Boccara, M Mary-Krause, E Teiger, S Lang, P Lim, K Wahbi, F Beygui, ... European heart journal 32 (1), 41-50, 2011 | 132 | 2011 |
| Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis M Melchior, A Nakamura, C Bolze, F Hausfater, F El Khoury, ... BMJ open 9 (7), e025880, 2019 | 123 | 2019 |
| Predictors identified for losses to follow-up among HIV-seropositive patients E Lanoy, M Mary-Krause, P Tattevin, R Dray-Spira, C Duvivier, P Fischer, ... Journal of clinical epidemiology 59 (8), 829-835. e1, 2006 | 111 | 2006 |
| Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy* S Grabar, E Lanoy, C Allavena, M Mary‐Krause, M Bentata, P Fischer, ... HIV medicine 9 (4), 246-256, 2008 | 101 | 2008 |
